ARTICLE
30 September 2015

Recap: Health Care Investors Summit – Exploring The Impact And Opportunities From Health Care Convergence

FL
Foley & Lardner

Contributor

Foley & Lardner LLP looks beyond the law to focus on the constantly evolving demands facing our clients and their industries. With over 1,100 lawyers in 24 offices across the United States, Mexico, Europe and Asia, Foley approaches client service by first understanding our clients’ priorities, objectives and challenges. We work hard to understand our clients’ issues and forge long-term relationships with them to help achieve successful outcomes and solve their legal issues through practical business advice and cutting-edge legal insight. Our clients view us as trusted business advisors because we understand that great legal service is only valuable if it is relevant, practical and beneficial to their businesses.
The 2015 Health Care Investors Summit, co-hosted by Foley and Deloitte & Touche, LLP, was held on September 24.
United States Food, Drugs, Healthcare, Life Sciences

The 2015 Health Care Investors Summit, co-hosted by Foley and Deloitte & Touche, LLP, was held on September 24. This program examined convergence in health care and the effects on investing, mergers and acquisitions, provider consolidation, partnerships, collaborations and related regulatory developments.

A robust discussion occurred between the keynotes as well as the panelists. Some key takeaways from those discussions are:

  • The current landscape of the health care industry needs collaboration across the entire care continuum.
  • Investment trends, associated opportunities and deal structures are being driven by market incentives and the implementation of the Affordable Care Act.
  • Convergence within the hospital and health plan sectors has presented strategic and operational challenges for hospitals and plans and has led to increased uniting of these institutions.
  • The industry trends related to acquisitions and mergers in the health care environment are still on the rise.

When dealing with the current challenges facing the market, consideration should be given to the wide array of legal issues arising from private equity investment, including considerations surrounding the structuring, negotiating, and executing of acquisitions, capital and growth financings, and dispositions of investments through sales, public offerings, and recapitalizations.

Speakers at the program included:

  • Opening Keynote, Mike Weissel, Executive Vice President and Chief Executive Officer of Consumer Solutions Group, Optum
  • Closing Keynote, Thomas M. Moriarty, Executive Vice President, Chief Health Strategy Officer and General Counsel, CVS Health
  • Derek Abruzzese, Chief Strategy Officer, Tufts Health Plan
  • Scott Barry, Managing Director, Essex Woodlands
  • Christopher J. Donovan, Partner, Health Care Industry Team, Foley & Lardner LLP
  • Max Lin, Director, Private Equity, Kohlberg Kravis Roberts & Co.
  • Bryan Martin, Partner, Deloitte & Touche LLP
  • Ollie McCoy, Principal, Life Sciences & Health Care, Deloitte & Touche LLP
  • Stephen Phenneger, Operating Partner, Cressey & Company
  • Mike Uchrin, Chief Executive Officer, Health Choice (a subsidiary of IASIS Healthcare)
  • J. Mark Waxman, Partner, Health Care Industry Team, Foley & Lardner LLP

Conclusion

Though the room recognized various challenges facing the health care industry they are optimistic that those challenges will present opportunities for growth, innovation and collaboration.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More